CRWD: the cashflow

MyFinsight

For the quarter ending 2025-10-31.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-10-31	2025-07-31	2025-04-30	2024-10-31
Net income (loss)	-222,626	-188,638	-110,993	76,135
Depreciation and amortization	180,883	116,834	56,423	137,851
Amortization of intangible assets	23,061	15,261	7,634	18,665
Amortization of deferred contract acquisition costs	325,434	209,941	102,903	227,713
Non-cash operating lease cost	12,625	8,717	4,186	11,100
Stock-based compensation expense	822,728	540,757	253,604	592,890
Deferred income taxes	-5,362	-2,320	-1,681	-2,122
Realized gains on strategic investments	0	0	0	6,227
Non-cash interest expense	-3,533	-2,293	-1,088	-2,748
Change in fair value of strategic investments	-1,579	-1,579	-1,579	-
Accretion of short-term investments purchased at a discount	0	0	0	-2,285
Accounts receivable, net	-116,196	-242,008	-319,871	-39,184
Deferred contract acquisition costs	431,660	251,622	102,803	361,412
Prepaid expenses and other assets	79,440	50,411	20,995	42,832
Accounts payable	-9,627	-13,310	-83,228	34,096
Accrued expenses and other liabilities	19,853	12,716	-43,763	85,667
Accrued payroll and benefits	32,607	-24,931	-37,848	89,896
Operating lease liabilities	-8,979	-8,113	-4,586	-11,812
Deferred revenue	333,675	106,178	42,716	142,180
Net cash provided by operating activities	1,114,480	716,939	384,107	1,036,005
Purchases of property and equipment	199,643	116,248	85,751	167,641
Capitalized internal-use software and website development costs	51,496	34,726	17,437	41,266
Purchases of strategic investments	10,267	1,417	374	12,702
Proceeds from sales of strategic investments	4,901	4,388	3,146	10,895
Business acquisitions, net of cash and restricted cash acquired	380,914	0	0	96,381
Purchases of intangible assets	-	-	-	0
Purchases of short-term investments	-	-	-	0
Proceeds from maturities and sales of short-term investments	0	0	0	97,300
Purchases of deferred compensation investments	4,257	2,770	1,459	1,815
Proceeds from sales of deferred compensation investments	173	164	45	41
Net cash used in investing activities	-641,503	-150,609	-101,830	-211,569
Proceeds from the issuance of common stock upon exercise stock options	2,628	2,355	634	3,308
Proceeds from issuance of common stock under the employee stock purchase plan	74,622	74,622	-	56,099
Distributions to non-controlling interest holders	2,156	2,156	0	4,085
Capital contributions from non-controlling interest holders	6,000	1,500	1,500	5,500
Net cash provided by financing activities	81,094	76,321	2,134	60,822
Effect of foreign exchange rates on cash, cash equivalents and restricted cash	7,317	6,595	6,546	-641
Net increase in cash, cash equivalents and restricted cash	561,388	649,246	290,957	884,617
Cash and cash equivalents at beginning of period	4,324,666	4,324,666	4,324,666	3,377,597
Cash and cash equivalents at end of period	4,886,054	4,973,912	4,615,623	4,262,214

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

CRWD: the cashflow